Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM® (monomethyl fumarate) product for the treatment of ...
One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback